Skip to main content
search

Strategic Leadership

Sign up

Latest resources

Featured resource

Upcoming strategic leadership webinars

Popular resources

Meet our experts at the following events

All Strategic Leadership resources

Strategic Project Management for Accelerated Drug Development

Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Fact Sheet

International PBPK Conference

Certara Products - Simcyp, Modeling and Simulation - PBPK, Conference

From Unstructured Data to Dose Insights: Applying Modern AI to Exposure Bracketing

Certara Products, Certara.AI, Webinar

New Approach Methodologies (NAMs): By the numbers

Certara Services, Modeling and Simulation, New Approach Methodologies (NAMs), Fact Sheet, Guide

Expedited Pharmacometrics Regulatory Submissions

Clinical Pharmacology, Clinical Trials, Model Informed Drug Development, Modeling and Simulation, Fact Sheet

The Stepwise PIP is Here to Stay: From Pilot Flexibility to Permanent EU Regulation

Certara Services, Modeling and Simulation, Pediatrics, Blog

From Insight to Impact: Certainty EMEA 2025

Certara Products, Certara Services, Blog

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

Certara Products, Certara Products - Phoenix, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, On-Demand Webinar

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, On-Demand Webinar

Build investor confidence with science-backed strategy

Certara Services, Fact Sheet

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Certara Services, Drug Development, Webinar

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Certara Services, Clinical Trials, Drug Development, Infectious Disease, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Therapeutic Specialties, Publication
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.